Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 194

1.

Comparison of rapid-cycling and non-rapid-cycling bipolar I manic patients during treatment with olanzapine: analysis of pooled data.

Vieta E, Calabrese JR, Hennen J, Colom F, Martínez-Arán A, Sánchez-Moreno J, Yatham LN, Tohen M, Baldessarini RJ.

J Clin Psychiatry. 2004 Oct;65(10):1420-8.

PMID:
15491248
2.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
3.

Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis.

Benazzi F, Berk M, Frye MA, Wang W, Barraco A, Tohen M.

J Clin Psychiatry. 2009 Oct;70(10):1424-31. doi: 10.4088/JCP.08m04772gre.

PMID:
19906346
4.

Long-term olanzapine therapy in the treatment of bipolar I disorder: an open-label continuation phase study.

Sanger TM, Grundy SL, Gibson PJ, Namjoshi MA, Greaney MG, Tohen MF.

J Clin Psychiatry. 2001 Apr;62(4):273-81.

PMID:
11379842
5.
6.

Differential efficacy of olanzapine and lithium in preventing manic or mixed recurrence in patients with bipolar I disorder based on number of previous manic or mixed episodes.

Ketter TA, Houston JP, Adams DH, Risser RC, Meyers AL, Williamson DJ, Tohen M.

J Clin Psychiatry. 2006 Jan;67(1):95-101.

PMID:
16426094
7.

Analyses of treatment-emergent mania with olanzapine/fluoxetine combination in the treatment of bipolar depression.

Keck PE Jr, Corya SA, Altshuler LL, Ketter TA, McElroy SL, Case M, Briggs SD, Tohen M.

J Clin Psychiatry. 2005 May;66(5):611-6.

PMID:
15889948
8.

A 24-week open-label extension study of olanzapine-fluoxetine combination and olanzapine monotherapy in the treatment of bipolar depression.

Corya SA, Perlis RH, Keck PE Jr, Lin DY, Case MG, Williamson DJ, Tohen MF.

J Clin Psychiatry. 2006 May;67(5):798-806.

PMID:
16841630
9.

Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial.

Tohen M, Greil W, Calabrese JR, Sachs GS, Yatham LN, Oerlinghausen BM, Koukopoulos A, Cassano GB, Grunze H, Licht RW, Dell'Osso L, Evans AR, Risser R, Baker RW, Crane H, Dossenbach MR, Bowden CL.

Am J Psychiatry. 2005 Jul;162(7):1281-90.

PMID:
15994710
10.

A rapid and systematic review and economic evaluation of the clinical and cost-effectiveness of newer drugs for treatment of mania associated with bipolar affective disorder.

Bridle C, Palmer S, Bagnall AM, Darba J, Duffy S, Sculpher M, Riemsma R.

Health Technol Assess. 2004 May;8(19):iii-iv, 1-187. Review.

11.

Olanzapine versus lithium in the acute treatment of bipolar mania: a double-blind, randomized, controlled trial.

Niufan G, Tohen M, Qiuqing A, Fude Y, Pope E, McElroy H, Ming L, Gaohua W, Xinbao Z, Huichun L, Liang S.

J Affect Disord. 2008 Jan;105(1-3):101-8. Epub 2007 May 24.

PMID:
17531327
12.

Olanzapine: new indication. Prevention of bipolar disorder: unconvincing trials.

[No authors listed]

Prescrire Int. 2005 Aug;14(78):140-2.

PMID:
16106596
13.

Reduced suicidal ideation in bipolar I disorder mixed-episode patients in a placebo-controlled trial of olanzapine combined with lithium or divalproex.

Houston JP, Ahl J, Meyers AL, Kaiser CJ, Tohen M, Baldessarini RJ.

J Clin Psychiatry. 2006 Aug;67(8):1246-52.

PMID:
16965203
14.

Use of olanzapine in the treatment of bipolar I disorder.

Lieberman DZ, Goodwin FK.

Expert Rev Neurother. 2004 Sep;4(5):759-67. Review.

PMID:
15853503
15.

Acute dysphoric mania: treatment response to olanzapine versus placebo.

Baker RW, Tohen M, Fawcett J, Risser RC, Schuh LM, Brown E, Stauffer VL, Shao L, Tollefson GD.

J Clin Psychopharmacol. 2003 Apr;23(2):132-7.

PMID:
12640214
16.

Clinical highlights in bipolar depression: focus on atypical antipsychotics.

Calabrese JR, Elhaj O, Gajwani P, Gao K.

J Clin Psychiatry. 2005;66 Suppl 5:26-33. Review.

PMID:
16038599
17.

Going up in smoke: tobacco smoking is associated with worse treatment outcomes in mania.

Berk M, Ng F, Wang WV, Tohen M, Lubman DI, Vieta E, Dodd S.

J Affect Disord. 2008 Sep;110(1-2):126-34. doi: 10.1016/j.jad.2008.01.018. Epub 2008 Feb 15.

PMID:
18280579
18.

Variables as mediators or moderators in predicting relapse to any type of mood episode in a bipolar maintenance study.

Tohen M, Wang WV, Leboyer M, Jen KY.

J Clin Psychiatry. 2012 Jul;73(7):e913-7. doi: 10.4088/JCP.10m06737.

PMID:
22901362
19.

Maintenance of response following stabilization of mixed index episodes with olanzapine monotherapy in a randomized, double-blind, placebo-controlled study of bipolar 1 disorder.

Tohen M, Sutton VK, Calabrese JR, Sachs GS, Bowden CL.

J Affect Disord. 2009 Jul;116(1-2):43-50. doi: 10.1016/j.jad.2008.11.003. Epub 2008 Dec 2.

PMID:
19054570
20.

Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression.

Tohen M, Vieta E, Calabrese J, Ketter TA, Sachs G, Bowden C, Mitchell PB, Centorrino F, Risser R, Baker RW, Evans AR, Beymer K, Dube S, Tollefson GD, Breier A.

Arch Gen Psychiatry. 2003 Nov;60(11):1079-88. Erratum in: Arch Gen Psychiatry. 2004 Feb;61(2):176.

PMID:
14609883

Supplemental Content

Support Center